Ken Tinebo
Ken TineboCEO
MBA, has more than 30 years of experience in the pharmaceutical industry and has held executive commercial roles at companies such as Danone Medical Nutrition, Orion Pharma, Astra Zeneca and Pharmacia.
Cernelle’s CEO since August 2015.
Björn Arnsvik
Björn ArnsvikHead of Facilities & EHS
MSc Mech Eng., has over 20 years of experience in the pharmaceutical industry and has held management positions at companies such as Astra Zeneca, Pharmacia and Thermo Fisher Scientific. Björn joined Cernelle in 2016.
Lena Cedergren
Lena CedergrenHead of Quality Control and Development
BSc Analytical Chemistry, has more than 25 years of experience mainly from the pharmaceutical industry. She has held executive analytical development roles at Pharmacia, Pfizer and Johnson & Johnson. Lena joined Cernelle in 2017.
Fredrik Håkansson
Fredrik HåkanssonCFO
MSc Economics and an Executive MBA, has more than 20 years of experience in managerial positions in various industries, including medicine technology and among others from companies such as Nolato and Enzymatica. Fredrik joined Cernelle in 2019.
Surinder Jossan
Surinder JossanHead of Regulatory Affairs & Quality Assurance
Fil.lic Molecular Biology, has more than 20 year of experience from the pharmaceutical companies like Bayer, Bioglan and from the Swedish Regulatory Health Authority – The Medical Products Agency. She has had senior roles within R&D Regulatory Affairs in different therapeutic areas. Surinder joined Cernelle in 2020.
Lena Ramnemark
Lena RamnemarkHead of Medical Research
MSc Chem Eng., has more than 30 years of experience from the pharmaceutical industry. She has held different positions within QC and R&D at Astra and Perstorp, and within Regulatory Affairs and Pharmacovigilance at Cernelle. Lena joined Cernelle in 1999.
Katarina Wilhelmsson
Katarina WilhelmssonHead of Operations
BSc Mech Eng., has more than 25 years of experience from companies such as SKF, Thorn Lighting and Johnson & Johnson where she has held managerial roles within Manufacturing, Supply Chain and Logistics. Katarina joined Cernelle in 2017.
Per-Anders Abrahamsson
Per-Anders AbrahamssonMember of the Board since 2015
MD, PhD, appointed as Associate Professor 1989 and Professor 2000 at Lund University, Adjunct Professor at the University of Rochester Medical Center, New York since 1993.
Dr. Abrahamsson has been working as a urologist for 40 years including 20 years as Head of the Department of Urology, Skåne University Hospital. He is currently acting as Immediate Past Secretary General of the European Association of Urology. Executive Medical Director at Ferring Pharmaceuticals A/S 2015 – 2018. Since 2018 Chief Medical Director, Peritus Clinic, Lund, Sweden.

Björn Dellgren
Björn DellgrenMember of the Board since 2008
Former CEO for Adenovir Pharma AB and Investments at P.U.L.S. AB (Sweden). Former Partner at BankInvest, (Denmark). Previous Director of Business Development at Pharmacia Corporation and various international positions in sales, marketing and business management at Pharmacia and the American pharmaceutical company, Lederle. Previous board member in Cellectis SA, (France), CliniGenetics SA, (France) and CMC Biologics, (Denmark).
Göran Hellström
Göran HellströmChairman of the Board since 2005
Partner and CEO at Navet AB. Chairman of the Board at Lunicore Studentkonsult AB. Board member at Lunds universitets stipendiestiftelse (LUSS).
Svante Paulsson
Svante PaulssonMember of the Board since 2007
Responsible for Projects and Strategic Affairs in Backahill AB. Board Member in Backahill AB and Rögle BK.
Ken Tinebo
Ken TineboCEO, Member of the Board since 2015
Ken Tinebo, MBA, has more than 30 years of experience in the pharmaceutical industry and has held executive commercial roles at companies such as Danone Medical Nutrition, Orion Pharma, Astra Zeneca and Pharmacia.
Cernelle’s CEO since August 2015.